Exact Mass: 490.1886
Exact Mass Matches: 490.1886
Found 181 metabolites which its exact mass value is equals to given mass value 490.1886
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
gamma-Secretase Inhibitor XXI
5alpha,6beta,8alpha,12alpha-Tetrahydroxy-28-norisotoonafolin
5-Hydroxy-7,4-dimethoxy-6,8-di-C-prenylflavanone 5-O-galactoside
7,8-trans-8,8-trans-7,8-cis-7-(5-methoxy-3,4-methylenedioxyphenyl)-7-(3,4,5-trimethoxyphenyl)-8-acetoxymethyl-8-hydroxymethyltetrahydrofuran
(5S)-6-O-(4-hydroxy cinnamoyl)-1-O-beta-D-glucopyranosyl-geraniol-5,10-olide|sibiraglycoside E
7-(2,3-Dihydroxy-3-methylbutoxy)-2-(3,4-dimethoxyphenyl)-3,5,8-trimethoxy-4H-1-benzopyran-4-one
(1betaH,5beta,6alpha,8beta,9beta,10alpha)-8-Angeloyl,6-(2,3-epoxy-2-methylbntanoyl):2,6,8-Trihydroxy-4(15),11(13)-elemadiene-3,1:12,9-diolide
(7S,8R)-dehydrodiconiferyl alcohol 9-beta-glucopyranoside
(2S,4R)-7-hydroxy-4-methoxy-6-methoxymethyl-8-methyl-4,2-oxidoflavan-5-O-beta-D-glucopyranoside|abacopterin H
1alpha-hydroperoxyligustrin-8-O-(4-hydroxy-5-O-sarracionyl)-sarracinate|1alpha-hydroperoxyligustrin-8-O-<4-hydroxy-5-O-sarracionyl>-sarracinate
2,3-trans-3,4-cis-3-acetoxymethyl-4-[(5-methoxy-3,4-methylenedioxyphenyl)(3,4,5-trimethoxyphenyl)methyl]tetrahydrofuran-2-ol
Asp Glu Ile Asp
Asp Asp Glu Ile
Asp Asp Glu Leu
Asp Asp Ile Glu
Asp Asp Leu Glu
Asp Glu Asp Ile
Asp Glu Asp Leu
Asp Glu Glu Val
Asp Glu Leu Asp
Asp Glu Val Glu
Asp Gly His Tyr
Asp Gly Asn Trp
Asp Gly Trp Asn
Asp Gly Tyr His
Asp His Gly Tyr
Asp His Tyr Gly
Asp Ile Asp Glu
Asp Ile Glu Asp
Asp Leu Asp Glu
Asp Leu Glu Asp
Asp Asn Gly Trp
Asp Asn Trp Gly
Asp Val Glu Glu
Asp Trp Gly Asn
Asp Trp Asn Gly
Asp Tyr Gly His
Asp Tyr His Gly
Glu Asp Asp Ile
Glu Asp Asp Leu
Glu Asp Glu Val
Glu Asp Ile Asp
Glu Asp Leu Asp
Glu Asp Val Glu
Glu Glu Asp Val
Glu Glu Val Asp
Glu Ile Asp Asp
Glu Leu Asp Asp
Glu Val Asp Glu
Glu Val Glu Asp
Gly Asp His Tyr
Gly Asp Asn Trp
Gly Asp Trp Asn
Gly Asp Tyr His
Gly His Asp Tyr
Gly His Tyr Asp
Gly Asn Asp Trp
Gly Asn Trp Asp
Gly Trp Asp Asn
Gly Trp Asn Asp
Gly Tyr Asp His
Gly Tyr His Asp
His Asp Gly Tyr
His Asp Tyr Gly
His Gly Asp Tyr
His Gly Tyr Asp
His Tyr Asp Gly
His Tyr Gly Asp
Ile Asp Asp Glu
Ile Asp Glu Asp
Ile Glu Asp Asp
Leu Asp Asp Glu
Leu Asp Glu Asp
Leu Glu Asp Asp
Asn Asp Gly Trp
Asn Asp Trp Gly
Asn Gly Asp Trp
Asn Gly Trp Asp
Asn Trp Asp Gly
Asn Trp Gly Asp
Val Asp Glu Glu
Val Glu Asp Glu
Val Glu Glu Asp
Trp Asp Gly Asn
Trp Asp Asn Gly
Trp Gly Asp Asn
Trp Gly Asn Asp
Trp Asn Asp Gly
Trp Asn Gly Asp
Tyr Asp Gly His
Tyr Asp His Gly
Tyr Gly Asp His
Tyr Gly His Asp
Tyr His Asp Gly
Tyr His Gly Asp
3,4,5-triethoxy-N-[3-[2-(1,2,4-oxadiazol-3-yl)pyridin-4-yl]oxyphenyl]benzamide
β-Funaltrexamine hydrochloride,(E)-4-[[5α,6β)-17-Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]amino]-4-oxo-2-butenoicacidmethylesterhydrochloride
Glasdegib maleate
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C188731 - Hedgehog Pathway Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor
gamma-Secretase Inhibitor XXI
D004791 - Enzyme Inhibitors > D000091062 - Gamma Secretase Inhibitors and Modulators
2-[5-[(Z)-[1-(4-tert-butylphenyl)-5-oxo-3-phenylpyrazol-4-ylidene]methyl]furan-2-yl]benzoic acid
1-(3-Carboxypropyl)-9-(dimethylamino)-11,11-dimethyl-2,3,4,11-tetrahydronaphtho[2,3-g]quinolinium perchlorate
N-benzyl-4-[2-[2-[(5-methyl-1H-pyrazol-3-yl)amino]-2-oxoethyl]sulfanyl-4-oxoquinazolin-3-yl]butanamide
N-[2-[1,3-benzodioxol-5-yl-[2-(cyclopentylamino)-2-oxo-1-pyridin-4-ylethyl]amino]-2-oxoethyl]-2-furancarboxamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[[(4R,5S)-8-(3-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclopropanecarboxamide
3-fluoro-N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylbenzamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-pyridinecarboxamide
N-[[(4S,5S)-8-(3-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclopropanecarboxamide
N-[[(4R,5R)-8-(3-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclopropanecarboxamide
N-[[(4S,5R)-8-(3-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclopropanecarboxamide
N-[[(4S,5R)-8-(3-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclopropanecarboxamide
N-[[(4S,5S)-8-(3-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclopropanecarboxamide
N-[[(4R,5S)-8-(3-fluorophenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclopropanecarboxamide
N-[[(4R,5R)-8-(3-fluorophenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methylcyclopropanecarboxamide
3-fluoro-N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylbenzamide
3-fluoro-N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylbenzamide
4-fluoro-N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylbenzamide
3,4,5-Trihydroxy-6-[2-[6-(2-methylbut-3-en-2-yl)-7-oxo-2,3-dihydrouro[3,2-g]chromen-2-yl]propan-2-yloxy]oxane-2-carboxylic acid
alpha-L-Fucp-(1->2)-[alpha-D-Galp-(1->3)]-D-Gal-OH
PGlu-3-methyl-His-Pro-NH2 (TFA)
PGlu-3-methyl-His-Pro-NH2 TFA (A-42872 TFA), the modified thyrotropin-releasing hormone (TRH) peptide, enhances binding to pituitary TRH receptors and increases stimulation of thyroid-stimulating hormone (TSH) release from the pituitary. The in vitro permeability of PGlu-3-methyl-His-Pro-NH2 TFA through rat skin is increased in the presence of enhancers Ethanol and Cineole[1][2].